Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F1M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,628
Award facts
- Contract value 100% obligated
- $15,627.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,627.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for STELARA 45 mg/0.5 mL syringes on January 15, 2026, with a completion date of January 16, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains extensive experience fulfilling federal pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support Medical IDC enables the contractor to supply essential medical commodities to defense health organizations, including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's capability to efficiently meet government requirements for critical pharmaceutical products in support of military treatment facilities and related federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F4F1M?
SPE2DR26F4F1M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F4F1M worth?
The government has obligated $15,628 on SPE2DR26F4F1M.
Is contract SPE2DR26F4F1M an order under another contract?
Yes. SPE2DR26F4F1M is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F1M competed?
The extent of competition for SPE2DR26F4F1M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award